Literature DB >> 19427113

Migration and actin protrusion in melanoma cells are regulated by EB1 protein.

Joseph M Schober1, Jeanine M Cain, Yulia A Komarova, Gary G Borisy.   

Abstract

Remodeling of actin and microtubule cytoskeletons is thought to be coupled; however, the interplay between these two systems is not fully understood. We show a microtubule end-binding protein, EB1, is required for formation of polarize morphology and motility of melanoma cells. EB1 depletion decreased lamellipodia protrusion, and resulted in loss of opposed protruding and retracting cell edges. Lamellipodia attenuation correlated with mis-localization of filopodia throughout the cell and decreased Arp3 localization. EB1-depleted cells displayed less persistent migration and reduced velocity in single-cell motility experiments. We propose EB1 coordinates melanoma cell migration through regulating the balance between lamellipodial and filopodial protrusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427113     DOI: 10.1016/j.canlet.2009.04.007

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  SCAR/WAVE is activated at mitosis and drives myosin-independent cytokinesis.

Authors:  Jason S King; Douwe M Veltman; Marios Georgiou; Buzz Baum; Robert H Insall
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

2.  The microtubule-associated protein EB1 maintains cell polarity through activation of protein kinase C.

Authors:  Joseph M Schober; Guim Kwon; Debbie Jayne; Jeanine M Cain
Journal:  Biochem Biophys Res Commun       Date:  2011-11-19       Impact factor: 3.575

Review 3.  Regulation of cell migration by dynamic microtubules.

Authors:  Irina Kaverina; Anne Straube
Journal:  Semin Cell Dev Biol       Date:  2011-10-04       Impact factor: 7.727

Review 4.  Targeting Microtubules for Wound Repair.

Authors:  Rabab A Charafeddine; Joshua D Nosanchuk; David J Sharp
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-10-01       Impact factor: 4.730

5.  Interactions between the Microtubule Binding Protein EB1 and F-Actin.

Authors:  Emily O Alberico; Zhiqing C Zhu; Yueh-Fu O Wu; Melissa K Gardner; Dave R Kovar; Holly V Goodson
Journal:  J Mol Biol       Date:  2016-02-06       Impact factor: 5.469

6.  RACK1 plays a critical role in mast cell secretion and Ca2+ mobilization by modulating F-actin dynamics.

Authors:  Edismauro G Freitas Filho; Elaine Z M da Silva; Hwei Ling Ong; William D Swaim; Indu S Ambudkar; Constance Oliver; Maria Célia Jamur
Journal:  J Cell Sci       Date:  2021-05-13       Impact factor: 5.285

7.  VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions.

Authors:  Yulia A Komarova; Fei Huang; Melissa Geyer; Nazila Daneshjou; Alexander Garcia; Luiza Idalino; Barry Kreutz; Dolly Mehta; Asrar B Malik
Journal:  Mol Cell       Date:  2012-11-15       Impact factor: 17.970

8.  Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes.

Authors:  Li-Jie Wang; Chia-Wei Hsu; Chiu-Chin Chen; Ying Liang; Lih-Chyang Chen; David M Ojcius; Ngan-Ming Tsang; Chuen Hsueh; Chih-Ching Wu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2012-08-06       Impact factor: 5.911

9.  Characterizing the role of the microtubule binding protein Bim1 in Cryptococcus neoformans.

Authors:  Mark W Staudt; Emilia K Kruzel; Kiminori Shimizu; Christina M Hull
Journal:  Fungal Genet Biol       Date:  2010-01-04       Impact factor: 3.495

10.  GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration.

Authors:  Massimilano Scolz; Per O Widlund; Silvano Piazza; Debora Rosa Bublik; Simone Reber; Leticia Y Peche; Yari Ciani; Nina Hubner; Mayumi Isokane; Martin Monte; Jan Ellenberg; Anthony A Hyman; Claudio Schneider; Alexander W Bird
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.